Chemotherapy for primary mediastinal yolk sac tumor in a patient undergoing chronic hemodialysis: a case report

BACKGROUND: The safety and efficacy of chemotherapy for patients undergoing concomitant hemodialysis have not been fully established and optimal doses of anti-cancer drugs and best timing of hemodialysis remains unclear. Although chemosensitive cancers, such as germ cell tumors, treated with chemoth...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Med Case Rep
Glavni autori: Hirakawa, Haruki, Nakashima, Chiho, Nakamura, Tomomi, Masuda, Masanori, Funakoshi, Taro, Nakagawa, Shunsaku, Horimatsu, Takahiro, Matsubara, Kazuo, Muto, Manabu, Kimura, Shinya, Sueoka-Aragane, Naoko
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312436/
https://ncbi.nlm.nih.gov/pubmed/28202048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-017-1213-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items